Clinical trial
Pulmonary Embolism: Mechanism and Therapeutic Innovation
NCT05360992 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pulmonary Embolism: Mechanism and Therapeutic Innovation
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2017
- Completion date
- October 13, 2021
- Enrollment
- 1,200 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.